Overview

Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia

Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This is a study to investigate the long-term safety and effectiveness [S,S]-Reboxetine in relieving the symptoms of Fibromyalgia in patients.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Reboxetine